PROVECTUS BIOPHARMACEUTICALS, INC. Business Finance Contracts & Agreements
48 Contracts & Agreements
- Escrow Agreements (1 contract)
- Exchange Agreements (1)
- Note Agreements (13)
- Purchase Agreements (3)
- Registration Rights Agreements (3)
- Stock Agreements (2)
- Subscription Agreements (4)
- Term Sheets (4)
- Underwriting Agreements (1)
- Waiver Agreements (1)
- Warrant Agreements (15)
- 2022 Financing Term Sheet (Filed With SEC on November 9, 2022)
- Form of Unsecured Convertible Promissory Note (Filed With SEC on September 26, 2022)
- 2021 Financing Term Sheet (Filed With SEC on November 10, 2021)
- Form of Unsecured Convertible Promissory Note (Filed With SEC on August 18, 2021)
- 2020 Definitive Financing Term Sheet (Filed With SEC on March 5, 2020)
- Form of PRH 2 Secured Convertible Promissory Note (Filed With SEC on January 7, 2020)
- Secured Convertible Promissory Note between the Company and Edward V. Pershing, dated July 26, 2018 (Filed With SEC on July 30, 2018)
- First Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and CAL Enterprises LLC, dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Fourth Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Third Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Second Amendment to Amended and Restated Secured Convertible Promissory Note between the Company and Eric Wachter, Ph.D., dated January 22, 2018 (Filed With SEC on May 9, 2018)
- Convertible Promissory Note between the Company and Timothy C. Scott, dated February 23, 2018 (Filed With SEC on February 26, 2018)
- Secured Convertible Promissory Note between the Company and Eric A. Wachter, dated January 25, 2018 (Filed With SEC on January 30, 2018)
- CONFIDENTIAL AMENDED AND RESTATEDDEFINITIVE FINANCING COMMITMENT TERM SHEET TO PROVECTUS BIOPHARMACEUTICALS,INC. DATED EFFECTIVE: March 19, 2017 (Filed With SEC on May 10, 2017)
- AMENDED AND RESTATED SECURED CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on April 4, 2017)
- SECURED CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on April 4, 2017)
- CONVERTIBLE PROMISSORY NOTE (this Note) (Filed With SEC on February 21, 2017)
- PROVECTUS BIOPHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on January 26, 2017)
- WARRANT AGENCY AGREEMENT (Filed With SEC on January 26, 2017)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on January 19, 2017)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on December 6, 2016)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on November 1, 2016)
- FORM OF NON-TRANSFERABLE SUBSCRIPTION RIGHTS CERTIFICATE (Filed With SEC on October 5, 2016)
- WARRANT AGENCY AGREEMENT (Filed With SEC on August 30, 2016)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on August 25, 2016)
- Form of Warrant PROVECTUS BIOPHARMACEUTICALS, INC. SERIES A WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on August 25, 2016)
- EXCHANGE ANDESCROW AGENT AGREEMENT (Filed With SEC on May 13, 2016)
- SECOND AMENDMENT TO WARRANT AGENCY AGREEMENT (Filed With SEC on May 13, 2016)
- EXCHANGE AND ESCROW AGENT AGREEMENT (Filed With SEC on December 31, 2015)
- FIRST AMENDMENT TO WARRANT AGENCY AGREEMENT (Filed With SEC on December 31, 2015)
- CONSENT AND WAIVER OF RIGHTS (Filed With SEC on June 24, 2015)
- [FORM OF COMMON STOCK WARRANT CERTIFICATE] (Filed With SEC on June 19, 2015)
- WARRANT AGENCY AGREEMENT (Filed With SEC on June 19, 2015)
- 17,500,000 SHARES OF COMMON STOCK AND 17,500,000WARRANTS OF PROVECTUS BIOPHARMACEUTICALS, INC. UNDERWRITING AGREEMENT (Filed With SEC on June 19, 2015)
- PROVECTUS BIOPHARMACEUTICALS, INC. Up to $50,000,000 of Shares ofCommon Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement (Filed With SEC on April 30, 2014)
- PURCHASE AGREEMENT (Filed With SEC on July 26, 2013)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 28, 2013)
- WARRANT (Filed With SEC on February 28, 2013)
- SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 28, 2013)
- WARRANT (Filed With SEC on April 20, 2011)